Clinical Outcomes of Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins: A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- bilateral uterine artery ligation
- Conditions
- Cesarean Section Complications
- Sponsor
- Aswan University Hospital
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- mean Blood loss after placental separation
- Last Updated
- 5 years ago
Overview
Brief Summary
Objective to assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage during cesarean delivery among women with twin pregnancy
Detailed Description
A randomized clinical trial at Aswan University Maternity Hospital, Egypt. Women with twin pregnancy undergoing scheduled or emergency cesarean were randomized into two groups. In the BUAL group, women underwent BUAL before placental delivery; in the control group, women had cesarean delivery without BUAL. The primary outcome was the estimated blood loss during a cesarean
Investigators
hany farouk
A Professor
Aswan University Hospital
Eligibility Criteria
Inclusion Criteria
- •women undergoing cesarean section
- •twin pregnancy
Exclusion Criteria
- •Placenta previa.
- •Ante-partum hemorrhage.
- •patient refuse to participate
Arms & Interventions
study group
patients with twin pregnancy undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
Intervention: bilateral uterine artery ligation
study group
patients with twin pregnancy undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
Intervention: Oxytocin
control group
patients with twin pregnancy undergoing cesarean section received oxytocin only.
Intervention: Oxytocin
Outcomes
Primary Outcomes
mean Blood loss after placental separation
Time Frame: 30 minutes
by using weight of soaked towels (weight of soaked towel - weight of dry towel) and amount of blood in suction set
Secondary Outcomes
- Number of Participants with postpartum hemorrhage(12 hours)
- The number of participant needed for blood transfusion(24 hours)